UK’s NICE Publishes Briefing Supporting PredictImmune Tool for Estimating IBD Flare-up Likelihood

UK’s NICE Publishes Briefing Supporting PredictImmune Tool for Estimating IBD Flare-up Likelihood
The National Institute for Health and Care Excellence (NICE) supports the use of PredictImmune's newly launched prognostic tool, PredictSURE IBD, for estimating the likelihoood of disease flare-ups in patients with inflammatory bowel disease (IBD), according to a published Medtech Innovation Briefing (MIB). PredictSURE IBD is a prognostic tool that estimates the chances of disease flare-ups in patients recently diagnosed with Crohn's disease or ulcerative colitis. It also will help physicians decide the best course of treatment for these patients. The tool was launched April 2 through Cambridge University Hospitals NHS Foundation Trust, and will be available to IBD patients in the United Kingdom and Ireland, according to a press release from PredictImmune. "It enables both clinicians and patients to understand, at the point of diagnosis, the likely course of disease — differentiating between an aggressive or milder form of the disease — and opens up the possibility of better treatment choices from the outset," the release states. PredictSURE IBD works by looking for specific genetic signatures using a technique called quantitative real-time polymerase chain rea
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *